Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.46
-0.02-0.45%
At close: -
$4.47
0.01000.22%
After Hours: 8:18 AM EDT
Comments
Loading...
TriSalus Life Sciences (NASDAQ:TLSI) Stock, Analyst Ratings, Price Targets, Forecasts
TriSalus Life Sciences Inc has a consensus price target of $12.3 based on the ratings of 5 analysts. The high is $16 issued by JonesTrading on May 10, 2024. The low is $10 issued by Oppenheimer on September 16, 2024. The 3 most-recent analyst ratings were released by Roth MKM, Northland Capital Markets, and Oppenheimer on November 11, 2024, October 25, 2024, and September 16, 2024, respectively. With an average price target of $11.17 between Roth MKM, Northland Capital Markets, and Oppenheimer, there's an implied 150.37% upside for TriSalus Life Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Northland Capital Markets
Oppenheimer
Canaccord Genuity
JonesTrading
1calculated from analyst ratings
Analyst Ratings for TriSalus Life Sciences
Data brought to you by Benzinga APIs
FAQ
What is the target price for TriSalus Life Sciences (TLSI) stock?
The latest price target for TriSalus Life Sciences (NASDAQ:TLSI) was reported by Roth MKM on November 11, 2024. The analyst firm set a price target for $11.00 expecting TLSI to rise to within 12 months (a possible 146.09% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TriSalus Life Sciences (TLSI)?
The latest analyst rating for TriSalus Life Sciences (NASDAQ:TLSI) was provided by Roth MKM, and TriSalus Life Sciences initiated their buy rating.
When was the last upgrade for TriSalus Life Sciences (TLSI)?
There is no last upgrade for TriSalus Life Sciences
When was the last downgrade for TriSalus Life Sciences (TLSI)?
There is no last downgrade for TriSalus Life Sciences.
When is the next analyst rating going to be posted or updated for TriSalus Life Sciences (TLSI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TriSalus Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TriSalus Life Sciences was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.
Is the Analyst Rating TriSalus Life Sciences (TLSI) correct?
While ratings are subjective and will change, the latest TriSalus Life Sciences (TLSI) rating was a initiated with a price target of $0.00 to $11.00. The current price TriSalus Life Sciences (TLSI) is trading at is $4.47, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.